Correction: Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach.

Xiao, Zhiguang; Sperl, Bianca; Gärtner, Silvia; Nedelko, Tatiana; Stacher-Priehse, Elvira; Ullrich, Axel; Knyazev, Pjotr G

Xiao, Zhiguang; Sperl, Bianca; Gärtner, Silvia; Nedelko, Tatiana; Stacher-Priehse, Elvira; Ullrich, Axel; Knyazev, Pjotr G.

Afiliação

Xiao Z; Department of Molecular Biology, Max-Planck Institute of Biochemistry, Martinsried, Munich, 82152, Germany.
Sperl B; Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Gärtner S; Department of Molecular Biology, Max-Planck Institute of Biochemistry, Martinsried, Munich, 82152, Germany.
Nedelko T; Department of Molecular Biology, Max-Planck Institute of Biochemistry, Martinsried, Munich, 82152, Germany.
Stacher-Priehse E; Department of Medicine III, Klinikum rechts der Isar, TUM, Munich, 81675, Germany.
Ullrich A; Asclepius Institute of Pathology, Gauting, 82131, Germany.
Knyazev PG; Department of Molecular Biology, Max-Planck Institute of Biochemistry, Martinsried, Munich, 82152, Germany.

Oncotarget ; 12(17): 1734-1735, 2021 Aug 17.

Article em En | MEDLINE | ID: mdl-34434503

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.18632/oncotarget.26817.].

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article